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genital ulcer disease (GUD). The second questionnaire targeted
pharmacists working in both public and private health care facili-
ties to elicit information on prescribing and dispensing practices.
RESULTS: The availability of acyclovir in the public sector was
a function of funding and prioritisation by policy makers. In
Zimbabwe and Zambia for example, acyclovir was unavailable
in the public sector because of a paucity of funds, while in Kenya,
Tanzania and South Africa, accessibility to acyclovir in the public
sector was poor because of low prioritisation by policy makers.
Acyclovir was available in the private sector, albeit at higher
prices than the private sector. Despite the availability of generic
formulations and the presence of competitive markets, acyclovir
was described as “poorly affordable” in the private sectors of all
countries except Botswana, South Africa and Zambia. Moreover,
private sector pharmacies used information asymmetry to inﬂate
the price of acyclovir generics from European countries as a
signal of quality. CONCLUSION: On-going clinical trials may
determine acyclovir to be effective in preventing the transmission
of human immunodeﬁciency virus (HIV) to susceptible patients.
However, for this research to transition into policy, certain fun-
damental issues will need to be addressed. These include: infor-
mation dissemination on the importance of acyclovir in GUD
and HIV to policy makers and the general public; and the need
for government intervention into competitive markets because of
inequalities to access and information asymmetry.
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OBJECTIVE: Hepatitis C virus (HCV) is a common blood-borne
infection in the US. Over time, patients with chronic HCV can
encounter serious complications that impose a signiﬁcant cost
burden to third party payers. In this study, we generated national
estimates of inpatient costs, length of stay (LOS), and probability
of death associated with four major chronic HCV-related com-
plications. METHODS: Discharge data for patients with chronic
HCV (ICD-9 070.44, 070.54, 070.70, or 070.71) were analyzed
using the 2005 HCUP Nationwide Inpatient Sample. Discharges
related to ascites, variceal bleeding, hepatic encephalopathy, and
hepatocellular carcinoma (hepatoma) were identiﬁed using rel-
evant ICD-9 diagnosis codes. Weighted estimates of costs, LOS,
and probability of death were calculated for stays related to these
complications. RESULTS: We identiﬁed a weighted total of
275,737 chronic HCV-related discharges. Approximately 11.5%
of these discharges were for ascites and 5.6% were for hepatic
encephalopathy. Admissions for variceal bleeding and hepatoma
were less common at 0.3% and 2.8%, respectively. Hepatoma,
however, was associated with the highest total inpatient costs
($17,609) and LOS (6.3 days). The probability of death from
hepatoma was 11%. Patients had 7.3 inpatient days on average
for ascites with a cost per day of $2125 and total inpatient cost
of $14,858. The probability of death from ascites was 9%. The
average number of inpatient days for hepatic encephalopathy
was 7 days with a cost per day of $1936, total inpatient cost of
$13,380, and probability of death of 11%. Patients with variceal
bleeding had the lowest inpatient costs ($12,128) and LOS (5.4
days). The probability of death from variceal bleeding (8%) was
lower compared to the other complications. CONCLUSION:
Advanced chronic HCV can lead to serious and costly com-
plications. Efforts to improve HCV treatment may help slow
disease progression and thus result in cost savings from avoided
complications.
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OBJECTIVE: Nosocomial infections are increasing. This study
focuses on soft tissue infections, S aureus infections and MRSA
nosocomial infections. Trends are quantiﬁed and analyzed for
hospital and patient characteristics. METHODS: Data from the
HCUP National Inpatient Sample (NIS) of US hospital discharges
for 1998 through 2004 were used to estimate national trends in
hospitalizations for three infectious conditions. Discharges where
ICD9-CMs were recorded for soft tissue infections (680.xx,
681.xx, and 682.xx), S aureus infections (038.11, 041.11, and
482.41), and MRSA (V09.0) were included in the study. NIS
discharge weights were used to generate nationally representative
estimates of discharges for each infection and for their combina-
tions with MRSA. Logistic regression was used to obtain odds
ratios (ORs) for each infection and MRSA combination (1 = yes,
0 = no) and the independent variables of patient age, race,
gender, income, hospital bedsize, location (urban/rural),
mission (teaching/non-teaching), and expected payment source.
RESULTS: From 1998 to 2004 discharges for soft tissue infec-
tions increased 47%, S aureus infections increased 28%, MRSA
increased 223%, MRSA with S aureus increased 317%, and
MRSA with soft tissue infection increased 608%. Regression
results for the S aureus with MRSA combination in 1998
revealed that being white, and older increased the odds of this
infection (ORs = 1.160 and 1.020 respectively) while being
female reduced the odds (OR = 0.692). Larger hospitals had a
lower odds (OR = 0.918) as did teaching hospitals (OR = 0.681).
However urban hospitals odds were higher (OR = 1.384) and
being a Medicare or Medicaid patient also was associated with
an increased odds of the infection (ORs = 1.486 and 1.743
respectively). Only patient income was not signiﬁcant (p < 0.001
for all other variables). Results for 2004 were similar but not
the same. CONCLUSION: Nosocomial infections continue to
increase as a percent of hospital stays, and the odds of infection
are not equal across patient and hospital types.
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To develop deterministic models for comparing the relative effec-
tiveness of various control measures, estimation of the spread
speed of the virus in the environment and the interactions
between spatial diffusion of birds and virus. Deterministic
models were developed based on the H5N1 transmission cycle by
partitioning the birds into three classes based on their epidemio-
logical characteristics for the disease under consideration:
poultry (c), wild birds—susceptible and die after H5N1 infection
(w), and wild birds—susceptible but survive after H5N1 infec-
tion without apparent disease symptoms (d). Model parameters
were obtained from existing literatures. Ordinary differential
equations (ODE) and partial differential equations (PDE) ana-
logues were utilized for the construction of models as described
below. ODE was used to access the effects of control measures,
one-dimensional PDE to study the spread speed of the disease,
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and two-dimensional PDE to examine how the epicenter moves
in space and time under different assumptions about the speed
and direction of poultry. ODE Simulations showed that by reduc-
ing 95% of the initial susceptible poultry population or by
culling all infected poultry birds within one day disease outbreak
could control lead in a local setting. Results further elucidated
that cleaning the environment is also a feasible and useful control
measure, but culling wild birds and destroying their habitat are
ineffective control measures. We noticed from the PDE models
that the diffusion rate of the (w) has very little impact on the
spread speed (1.69–1.74 km/day) where as (d) has shown sub-
stantial raise of spread speed (2–7.8 km/day) depending on the
transmission direction indicating signiﬁcant role of migration.
Finally, we assumed that epicenter progresses dominantly along
the convection direction of the domestic poultry and the disease
spread to other direction via random diffusion. Mathematical
modeling could prove effective in answering epidemiological
issues.
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OBJECTIVE: Determine the initial therapy choices for newly-
diagnosed episodes of acute otitis externa (AOE) in the Louisiana
Medicaid population. METHODS: Louisiana Medicaid claims
were retrospectively analyzed for the period of January 1, 2004,
through December 31, 2005. Recipients aged 1–64 who had a
paid medical claim (index claim) with a diagnosis of AOE (ICD-
9-CM codes 380.10 or 380.12) were identiﬁed in the dataset.
Additional inclusion criteria included a paid pharmacy claim for
an oral antibiotic or an otic preparation within ﬁve days of the
index claim. Recipients were excluded if they had multiple insur-
ances, dual antibiotic or additional numbing agent therapy,
co-morbid conditions, or concomitant infections. Recipients
were also excluded if they had a medical claim for an AOE
diagnosis or a prescription claim for an antibiotic or steroid
during a 30-day washout period prior to the index claim. The
initial pharmacy claims were grouped into ﬁve drug categories,
and physicians were grouped as pediatricians, general practitio-
ners, and other physicians. RESULTS: There were 32,059 recipi-
ents who met the initial eligibility criteria. After exclusions, a
sample of 8090 recipients remained. The initial drug therapies
prescribed for these recipients included topical ﬂuoroquino-
lone antibiotic-steroid combination drugs (n = 2290), topical
non-ﬂuoroquinolone antibiotic-steroid combination drugs (n =
2006), otic antibiotics (n = 1406), oral antibiotics (n = 1507),
and other otic preparations including acidifying agents, numbing
agents, and combinations (n = 881). CONCLUSION: Topical
ﬂuoroquinolone or non-ﬂuoroquinolone antibiotic-steroid com-
binations were the most frequently prescribed medications,
together representing 53% of the initial therapy choices for AOE.
These were followed by oral antibiotics (19%), otic antibiotics
(17%), and other otic preparations (11%). Pediatricians pre-
scribed ﬂuoroquinolone containing combinations more fre-
quently than general practitioners, who tended to prescribe
non-ﬂuoroquinolone containing combinations most frequently.
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OBJECTIVE: Despite numerous advances in antiretroviral
therapy (ART) for HIV patients over the past decade, many
patients fail to receive appropriate ART. This study sought to
identify demographic factors associated with failure to receive
guideline-concordant ART. METHODS: Data was extracted
from the 2000–2005 NAMCS. HIV patients were deﬁned as
those that received at least one antiretroviral during an ambula-
tory care visit. Data collected included patient age, gender, race,
ethnicity, geographic region, insurance status, and medications.
Antiretroviral regimens were evaluated for appropriateness
according to antiretroviral guidelines published by the Depart-
ment of Health and Human Services. Appropriate and inappro-
priate regimens were compared using the Chi-square or Fisher’s
Exact test. RESULTS: Antiretroviral therapy was mentioned in
107 of 156,627 visits. These patients had a median (25th–75th
percentile) age of 45 (38–54) years, 66% were male, 64% were
white, and 42% had Medicaid/SCHIP. Only 58% of patient visits
documented appropriate ART. These consisted of two nucleoside
reverse transcriptase inhibitors (NRTIs) plus one non-nucleoside
reverse transcriptase inhibitor (NNRTI) (36%), two NRTIs plus
two protease inhibitors (PIs) (26%), or two NRTIs plus PI
(11%). Inappropriate monotherapy was commonly reported:
NRTI (30%), PI (16%), or NNRTI (12%) monotherapy. Patients
were less likely to receive appropriate therapy if they were 50
years of age (23% vs. 49%, p = 0.003) or had Medicare (5% vs.
23%, p = 0.005). All Asian patients in the surveys received inap-
propriate therapy (p = 0.007 vs. non-Asians). Comparisons of
appropriate ART use among females vs. males (30% vs. 47%,
p = 0.08) and whites vs. non-whites (63% vs. 67%, p = 0.6);
failed to achieve statistical signiﬁcance. However, the post-hoc
power for these statistics was only 42% and 6%, respectively.
CONCLUSION: Nearly half of patients in the 2000–2005
NAMCS received suboptimal HIV therapy. Asian patients, Medi-
care patients, and those patients over the age of 50 years were
signiﬁcantly less likely to receive guideline-endorsed therapies.
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OBJECTIVE: To analyze the trend in antiviral prescriptions for
patients with inﬂuenza from 1999–2005. METHODS: This is a
cross-sectional database analysis using data from the NAMCS
(National ambulatory medical care survey) and NHAMCS
(National hospital ambulatory medical care survey) for the years
1999–2005. Records were extracted for ofﬁce and hospital based
physician-patient encounters having a diagnosis of inﬂuenza
(ICD-9-CM codes 487.0, 487.1, 487.8). The rate of neuramini-
dase inhibitors (NI) and adamantanes prescribed per 1000
patients with inﬂuenza was determined. The association between
the type of antiviral drug and the physician specialty, region,
patient sex, and patient age was evaluated by adjusted odd ratios.
Data were analyzed with Proc logistic regression with adjusted
odds ratios by years using SAS® 9.1.3. RESULTS: The prescrib-
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